Immune Modifications in Fetal Membranes Overlying the Cervix Precede Parturition in Humans
Louis Marcellin(Délégation Paris 5), Céline Méhats(Délégation Paris 5), Alain Schmitt(Institut de Microbiologie de la Méditerranée), Sébastien Jacques(Centre National de la Recherche Scientifique), Driss Chader(Inserm), D. Cabrol(Délégation Paris 5), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Guy Gorochov(Inserm), Daniel Vaiman(Centre National de la Recherche Scientifique), Corinne Lesaffre(Délégation Paris 5), Jérémy Delaire(Délégation Paris 5), François Goffinet(Inserm), Anne Caignard(Inserm), Thomas Schmitz(Université Paris Cité), Christophe Parizot(Inserm), Michelle Breuiller-Fouché(Délégation Paris 5), Jean Gogusev(Délégation Paris 5)
Cited by 44
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
|Nature Medicine|2022|637
Classification of current anticancer immunotherapies
|Oncotarget|2014|469